# Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy

> **NCT07028528** · PHASE2 · RECRUITING · sponsor: **RDC Clinical Pty Ltd** · enrollment: 80 (estimated)

## Conditions studied

- Diabetic Peripheral Neuropathy

## Interventions

- **DIETARY_SUPPLEMENT:** Levagen+
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07028528
- **Lead sponsor:** RDC Clinical Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07028528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07028528, "Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07028528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*